Welcome at the Institute for Experimental Molecular Imaging
Since 2008, the Institute for Experimental Molecular Imaging has been pursuing the development and evaluation of novel imaging modalities, contrast agents and theranostics for the characterization and treatment of cancer, cardiovascular and inflammatory diseases. These are characterized by consistent interdisciplinarity and thus represent a living example of the increasingly cited convergence of disciplines.
The RWTH Aachen University with its technical faculties, the Faculty of Natural Sciences and the Faculty of Medicine with the directly neighboring University Hospital offers excellent conditions for this research environment.
Thus, scientists and students from the engineering sciences, medicine, biology, physics, computer science and chemistry work together in multiple research and development projects at our institute.
Internationalization also runs through all levels of our institute and changes it in a far-reaching and sustainable way. This is important to us because global thinking and a perspective that goes beyond the boundaries of one's own horizon is crucial for education, research and the future of our society. In the search for excellent solutions to the global research challenges of our time, we rely on creativity, diversity and internationality. Currently, ExMI has employees from over 15 different countries.
Our research and development work includes simulation, modeling, design, prototyping, and the experimental validation and preclinical testing of medical devices and theranostics. In addition, we accompany innovative procedures and products in clinical studies.
The institute is part of the Helmholtz Institute for Biomedical Engineering at RWTH Aachen University and is partly located in the research building CBMS, the Center for Biohybrid Medical Systems.
Further areas of the institute are located in the Medical Technology Center MTZ and the Center for Biomedical Engineering ZBMT building on Pauwelstrasse, about 50 m away from CBMS.